ZLZhenyu Liang

Zhenyu Liang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zhenyu Liang has a total of 253 co-authors. Here are the top co-authors by number of shared publications:

  • Rongchang Chen

    Department of Pulmonary and Critical Care Medicine, Shenzhen Key Laboratory of Respiratory Diseases, Shenzhen Clinical Research Center for Respiratory Disease, Shenzhen Institute of Respiratory Diseases, The First Affiliated Hospital, The Second Clinical Medical College, Shenzhen People’s Hospital, Southern University of Science and Technology, Jinan University, Shenzhen, China

    19 shared publications
  • Fengyan Wang

    State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

    10 shared publications
  • Yuqiong Yang

    State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Joint International Research Laboratory of Respiratory Health, Guangdong Basic Research Center of Excellence for Respiratory Medicine, Department of Respiratory Medicine, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China

    10 shared publications
  • Rongchang Chen

    Department of Pulmonary and Critical Care Medicine, Shenzhen Institute of Respiratory Disease, Shenzhen People's Hospital, Shenzhen, China

    8 shared publications
  • Shouliang Qi

    College of Medicine and Biological Information Engineering, Northeastern University, Shenyang, China

    8 shared publications
  • Jiaxuan Xu

    State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The National Center for Respiratory Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

    7 shared publications

Latest Publications

  • Quantitative CT–Derived extrapulmonary body composition and the risk of acute exacerbations in COPD: A prospective cohort study

    by Chengyu Miao, Shengchuan Feng, Fengyan Wang, Yuqiong Yang, Zizheng Chen, Xueping Li, Zifei Zhou, Fangcheng Liu, Rongchang Chen, Zhenyu Liang

  • Accurate segmentation of pulmonary arteries and veins via a human-in-the-loop framework with application in COPD

    by Patrice Monkam, Xin Du, Yanan Wu, Tiande Zhang, Jiaxuan Xu, Jie Feng, Rongchang Chen, Zhenyu Liang, Shouliang Qi

  • Open Access

    The relevance of sputum galectin-7 levels to clinical and prognostic factors in patients with chronic obstructive pulmonary disease: a prospective cohort study from China

    by Wenqiang He, Xueping Li, Haining Huang, Zitong Tang, Junqing Zhu, Yuqiong Yang, Zizheng Chen, Chengyu Miao, Huajing Yang, Shanshan Zha, et al.

    Objective: Galectin-7, a β-galactoside-binding lectin involved in inflammation, immune regulation, and apoptosis, has been implicated in the development and progression of various lung diseases. Inflammation, immune dysregulation, and epithelial cell apoptosis are key pathophysiological mechanisms underlying chronic obstructive pulmonary disease (COPD). However, the clinical significance of galectin-7 in COPD remains unclear. This study aimed to investigate the association between sputum galectin-7 levels and the clinical characteristics and prognosis of patients with COPD. Methods: In this prospective study, 150 patients with stable COPD and 50 healthy controls were enrolled. Demographic data, clinical parameters, and sputum samples were collected. Baseline galectin-7 concentrations in sputum supernatants were measured using an enzyme-linked immunosorbent assay (ELISA). Patients with COPD were followed for one year to document acute exacerbation events. Among COPD patients, Spearman correlation analysis and multivariable linear regression were performed to examine the associations between galectin-7 levels and clinical parameters or inflammatory markers, adjusting for sex, age, smoking status, and body mass index (BMI). Multivariable Poisson regression and logistic regression models were further applied to assess the relationship between galectin-7 levels and acute exacerbations within one year, with adjustment for the number of exacerbations in the previous year, sex, age, smoking status, BMI, and post-bronchodilator FEV1% predicted (Post-BD FEV1% pred). Results: After adjustment in the analysis of covariance, galectin-7 levels were significantly lower in patients with GOLD III–IV than in healthy controls and patients with GOLD I–II (P < 0.05). Multivariable linear regression analyses indicated that galectin-7 levels were significantly associated with multiple clinical indicators and inflammatory markers. In the multivariable Poisson regression model, each 10 ng/mL increase in sputum galectin-7 was associated with a 15.7% reduction in the risk of acute exacerbations within one year (RR, 0.843; 95% CI, 0.716–0.973; P = 0.028). In the multivariable logistic regression model, each 10 ng/mL increase in sputum galectin-7 was associated with a 35.1% lower risk of frequent acute exacerbations within one year (OR, 0.649; 95% CI, 0.424–0.923; P = 0.029). Conclusion: Lower sputum galectin-7 levels are associated with later stages and an increased risk of future acute exacerbations in COPD, suggesting that galectin-7 may be a promising biomarker related to disease severity and prognosis. Trial Registration: This study was registered in the International Clinical Trials Registry (NCT03240315). Trial registration on July 31, 2017.

  • Open Access

    Sputum proteomics and phosphoproteomics for improving chronic obstructive pulmonary disease knowledge

    by Fei Long, Xiaoyin Zeng, Fengyan Wang, Xufei Wang, Weijuan Shi, Yanting Lan, Jiahao Cheng, Chen Zhu, Yiqi Yang, Jing Xiao, et al.

  • Open Access

    Association of respiratory symptom profiles with future exacerbations and lung function decline in mild-to-moderate COPD

    by Huajing Yang, Shiying Fang, Yuqiong Yang, Gengjia Chen, Shanshan Zha, Chengyu Miao, Zizheng Chen, Xueping Li, Zifei Zhou, Wenqiang He, et al.

    Background: The prognostic value of respiratory symptom profiles for predicting exacerbation risk and lung function decline remains unclear in mild-to-moderate chronic obstructive pulmonary disease (COPD). Research question: Are respiratory symptom profiles associated with both exacerbation risk and lung function decline in mild-to-moderate COPD? Study design and methods: This was a posthoc analysis of data from participants with mild-to-moderate COPD from the SubPopulations and InteRmediate Outcome Measures in COPD Study. Respiratory symptom profiles were identified through latent class analysis. Outcomes included exacerbation rates evaluated by zero-inflated negative binomial regressions, time-to-first exacerbation evaluated by Cox regression and longitudinal forced expiratory volume in 1 second (FEV 1 ) decline evaluated by linear mixed-effects models. Results: Among the 954 participants with mild-to-moderate COPD, five distinct respiratory symptom profiles were identified. Compared with the ‘minimal respiratory’ profile, the ‘productive cough’ profile was associated with a higher rate of any respiratory exacerbations (relative ratio [RR] 1.84; 95% confidence interval [CI] 1.29 to 2.64) and severe respiratory exacerbations (RR 2.05; 95% CI 1.12 to 3.74). Similarly, the ‘Wheeze’ profile was associated with higher rates of any (RR 1.55; 95% CI 1.12 to 2.15) and severe exacerbations (RR 1.73; 95% CI 1.00 to 2.98). The ‘nearly all respiratory symptoms’ profile was associated with a higher rate of exacerbations (any exacerbation: RR 2.12; 95% CI 1.56 to 2.89; severe exacerbations: RR 2.07; 1.23 to 3.47) and an accelerated annual FEV 1 decline (−15.41 mL/year; 95% CI −30.33 to −0.51 mL/year). The ‘dry cough’ profile exhibited the lowest FEV 1 trajectory despite a non-significant annual decline. Interpretation: Respiratory symptom profiles identifies distinct prognostic outcomes in mild-to-moderate COPD. The productive cough is associated with increased exacerbation risk, while the dry cough is associated with a lower lung function trajectory. Trial registration number: NCT0196934 .


  • Open Access

    A self-training framework for semi-supervised pulmonary vessel segmentation and its application in COPD

    by Shuiqing Zhao, Meihuan Wang, Jiaxuan Xu, Jie Feng, Wei Qian, Rongchang Chen, Zhenyu Liang, Shouliang Qi, Yanan Wu

    Background: It is fundamental for accurate segmentation and quantification of the pulmonary vessel, particularly smaller vessels, from computed tomography (CT) images in chronic obstructive pulmonary disease (COPD) patients. Objective: The aim of this study was to segment the pulmonary vasculature using a semi-supervised method. Methods: In this study, a self-training framework is proposed by leveraging a teacher-student model for the segmentation of pulmonary vessels. First, the high-quality annotations are acquired in the in-house data by an interactive way. Then, the model is trained in the semi-supervised way. A fully supervised model is trained on a small set of labeled CT images, yielding the teacher model. Following this, the teacher model is used to generate pseudo-labels for the unlabeled CT images, from which reliable ones are selected based on a certain strategy. The training of the student model involves these reliable pseudo-labels. This training process is iteratively repeated until an optimal performance is achieved. Results: Extensive experiments are performed on non-enhanced CT scans of 125 COPD patients. Quantitative and qualitative analyses demonstrate that the proposed method, Semi2, significantly improves the precision of vessel segmentation by 2.3%, achieving a precision of 90.3%. Further, quantitative analysis is conducted in the pulmonary vessel of COPD, providing insights into the differences in the pulmonary vessel across different severity of the disease. Conclusion: The proposed method can not only improve the performance of pulmonary vascular segmentation, but can also be applied in COPD analysis. The code will be made available at https://github.com/wuyanan513/semi-supervised-learning-for-vessel-segmentation .


  • The Identification and Severity Staging of Chronic Obstructive Pulmonary Disease Using Quantitative CT Parameters, Radiomics Features, and Deep Learning Features

    by Shengchuan Feng, Wenxiu Zhang, Ran Zhang, Yuqiong Yang, Fengyan Wang, Chengyu Miao, Zizheng Chen, Kai Yang, Qing Yao, Qing Liang, et al.

    Introduction: The aim of the study was to evaluate the value of quantitative CT (QCT) parameters, radiomics features, and deep learning (DL) features based on inspiratory and expiratory CT for the identification and severity staging of chronic obstructive pulmonary disease (COPD). Methods: This retrospective analysis included 223 COPD patients and 59 healthy controls from the Guangzhou cohort. We stratified the participants into a training cohort and a testing cohort (7:3) and extracted DL features based on VGG-16 method, radiomics features based on pyradiomics package, and QCT parameters based on NeuLungCARE software. The logistic regression method was employed to construct models for the identification and severity staging of COPD. The Shenzhen cohort was used as the external validation cohort to assess the generalizability of the models. Results: In the COPD identification models, model 5-B1 (the QCT combined with DL model in biphasic CT) showed the best predictive performance with AUC of 0.920 and 0.897 in testing cohort and external validation cohort, respectively. In the COPD severity staging models, the predictive performance of model 4-B2 (the model combining QCT with radiomics features in biphasic CT) and model 5-B2 (the model combining QCT with DL features in biphasic CT) was superior to that of the other models. Conclusion: This biphasic CT-based multimodal approach integrating QCT, radiomics, or DL features offers a clinically valuable tool for COPD identification and severity staging.


  • Response

    by Huajing Yang, Zhenyu Liang

  • Open Access

    A Self-training Framework for Semi-supervised Pulmonary Vessel Segmentation and Its Application in COPD

    by Shuiqing Zhao, Meihuan Wang, Jiaxuan Xu, Jie Feng, Wei Qian, Rongchang Chen, Zhenyu Liang, Shouliang Qi, Yanan Wu

    Background: It is fundamental for accurate segmentation and quantification of the pulmonary vessel, particularly smaller vessels, from computed tomography (CT) images in chronic obstructive pulmonary disease (COPD) patients. Objective: The aim of this study was to segment the pulmonary vasculature using a semi-supervised method. Methods: In this study, a self-training framework is proposed by leveraging a teacher-student model for the segmentation of pulmonary vessels. First, the high-quality annotations are acquired in the in-house data by an interactive way. Then, the model is trained in the semi-supervised way. A fully supervised model is trained on a small set of labeled CT images, yielding the teacher model. Following this, the teacher model is used to generate pseudo-labels for the unlabeled CT images, from which reliable ones are selected based on a certain strategy. The training of the student model involves these reliable pseudo-labels. This training process is iteratively repeated until an optimal performance is achieved. Results: Extensive experiments are performed on non-enhanced CT scans of 125 COPD patients. Quantitative and qualitative analyses demonstrate that the proposed method, Semi2, significantly improves the precision of vessel segmentation by 2.3%, achieving a precision of 90.3%. Further, quantitative analysis is conducted in the pulmonary vessel of COPD, providing insights into the differences in the pulmonary vessel across different severity of the disease. Conclusion: The proposed method can not only improve the performance of pulmonary vascular segmentation, but can also be applied in COPD analysis. The code will be made available at https://github.com/wuyanan513/semi-supervised-learning-for-vessel-segmentation.

  • Open Access

    Quality of Care and Outcomes of Inpatients with COPD: A Multi-Center Study in China

    by Fengyan Wang, Mingdie Wang, Xiaoyan Chen, Aiqi Song, Hui Zeng, Jiawei Chen, Lingwei Wang, Wanyi Jiang, Mei Jiang, Weijuan Shi, et al.

    Objective: Hospitalization due to chronic obstructive pulmonary disease (COPD) exacerbation is linked to worse prognosis and increased healthcare burden, especially in low- and middle-income countries. This study aimed to evaluate the quality of care and outcomes among inpatients with COPD and to identify prognostic factors relate to healthcare quality indicators. Methods: A multi-center, retrospective longitudinal study was conducted. Patients hospitalized for COPD exacerbations between January and December 2017 were randomly sampled from 16 secondary or tertiary public general hospitals in China. Healthcare quality process indicators and clinical outcomes were collected from medical records and patient questionnaires. The median follow-up period was 666 days. Multivariate logistic regression analysis was used to identify risk factors for readmission or death within 30 days after discharge and for one-year mortality. Results: A total of 891 inpatients with COPD were included. Among them, 14.3% underwent post-bronchodilator spirometry. Documentation of exacerbation history and symptom scores was found in 16.8% and 1.2% of medical records, respectively. Long-acting bronchodilators (LABDs) were prescribed at discharge in 30.3% of cases. Verbal counseling was the primary approach to smoking cessation education, rather than the 5A method. The 30-day readmission rate was 7.1%. The average exacerbation rate was 0.94 per patient during the following year, and the one-year mortality rate was 7.2%. Prescription of inhaled LABDs at discharge was significantly associated with a lower risk of readmission or death within 30 days (HR 0.51, 95% CI 0.29– 0.90, p=0.020). The presence of cardiovascular disease was associated with an increased risk of death within one year (HR 2.34, 95% CI 1.24– 4.41, p=0.002). Conclusion: The quality of inpatient care for COPD in China showed deficiencies in diagnostics, disease assessment, and patient education. Prescription of inhaled LABDs at discharge was a key quality measure that significantly reduced short-term readmission or mortality, highlighting its importance. Standardized protocols and clinician training are essential to improve patient outcomes.